Sunitinib Malate in the Treatment of Metastatic Renal Cell Carcinoma: the North of England Cancer Network (NECN) Experience von Goranova, R.A, Goranov, B.B, Pedley, I.D, Azzabi, A, Humphreys, A, McMenemin, R, Frew, J.A

Volltext

Clinical Outcomes of a Phase II Open-labelled, Randomised Study Investigating the Tolerability and Efficacy of Anti-androgen Manipulation versus Taxotere and Anti-androgen Manipula... von Wilson, J, Al-Naeeb, A.B, Razak, A.R.A, Frew, J.A, Azzabi, A, McMenemin, R, Soomro, N, Durkan, G, Leung, H, Pedley, I.D

Volltext

673P Assessing bone health and osteoporotic risk in patients requiring anti androgen therapy for prostate cancer von Hannaway, N., Jiang, X., Aspray, T., Burns, A., Ferguson, J., Pedley, I.D., Frew, J., Azzabi, A., Pearson, R., Chandler, R., Hughes, A., Showler, H., Bennett, A., McMenemin, R.

Volltext

Optimising Radium 223 Therapy for Metastatic Castration-Resistant Prostate Cancer –5-year Real-World Outcome: Focusing on Treatment Sequence and Quality of Life von Jiang, X.Y., Atkinson, S., Pearson, R., Leaning, D., Cumming, S., Burns, A., Azzabi, A., Frew, J., McMenemin, R., Pedley, I.D.

Volltext

Prostate Ultrahypofractionation – Rising to Challenges Presents Opportunities in the COVID-19 Era von Griffiths, W., Frew, J.A., Chandler, R., Jiang, X.Y., Pedley, I.D., Pearson, R.A.

Volltext

LBA4 Abiraterone acetate plus prednisolone (AAP) with or without enzalutamide (ENZ) added to androgen deprivation therapy (ADT) compared to ADT alone for men with high-risk non-met... von Attard, G., Brown, L.C., Clarke, N., Murphy, L., Cross, W., Jones, R., Gillessen, S., Russell, J.M., Cook, A., Bowen, J., Lydon, A., Pedley, I.D., Parikh, O., Chowdhury, S., Malik, Z., Matheson, D., Parker, C., Sydes, M.R., Parmar, M.K., James, N.D.

Volltext

Magnetic Resonance-only Workflow: Implementation in a UK Centre von Pearson, R.A., Brooks, R., Driver, S., Frew, J.A., Pedley, I.D., Pilling, K., Richmond, N., Walker, C., West, S., Wilkinson, M., Wyatt, J., McCallum, H.

Volltext

Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre-and post-treatment prostatic biopsies from patients with advanced prostate cancer von Rajan, P, Stockley, J, Sudbery, I.M, Fleming, J.T, Hedley, A, Kalna, G, Sims, D, Ponting, C.P, Heger, A, Robson, C.N, McMenemin, R.M, Pedley, I.D, Leung, H.Y

Volltext bestellen